ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Celyad Oncology SA

Celyad Oncology SA (CYAD)

0.2505
-0.0075
( -2.91% )
Updated: 05:57:42

Professional-Grade Tools, for Individual Investors.

Key stats and details

Current Price
0.2505
Bid
0.2505
Ask
0.2715
Volume
18,629
0.25 Day's Range 0.2715
0.231 52 Week Range 1.28
Market Cap
Previous Close
0.258
Open
0.262
Last Trade
300
@
0.2505
Last Trade Time
05:57:42
Financial Volume
-
VWAP
-
Average Volume (3m)
15,135
Shares Outstanding
41,429,000
Dividend Yield
-
PE Ratio
-1.32
Earnings Per Share (EPS)
-0.2
Revenue
102k
Net Profit
-8.45M

About Celyad Oncology SA

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Website
Headquarters
Wavre, Walloon Brabant, Bel
Founded
1970
Celyad Oncology SA is listed in the Pharmaceutical Preparations sector of the Euronext with ticker CYAD. The last closing price for Celyad Oncology was 0.26 €. Over the last year, Celyad Oncology shares have traded in a share price range of 0.231 € to 1.28 €.

Celyad Oncology currently has 41,429,000 shares outstanding. The market capitalization of Celyad Oncology is 10.69 € million. Celyad Oncology has a price to earnings ratio (PE ratio) of -1.32.

CYAD Latest News

Celyad Oncology announces intention to terminate SEC reporting obligations

MONT-SAINT-GUIBERT, Belgium, Feb. 08, 2024 (GLOBE NEWSWIRE) -- Celyad Oncology SA (Euronext: CYAD) (“Celyad Oncology” or the “Company”) announces that it will voluntarily file a Form 15F with...

Celyad Oncology provides fourth quarter 2023 business update and 2024 outlook

Three main pillars to unlock the potential of proprietary technology platforms and intellectual property: A proprietary non-gene editing technology platform based on multiplexing of short hairpin...

Publication of a transparency notification received from Fortress Investment Group LLC (Article 14 §1 of the Law of 2 May 2007)

MONT-SAINT-GUIBERT, Belgium, Dec. 20, 2023 (GLOBE NEWSWIRE) -- Celyad Oncology SA (Euronext: CYAD) (“Celyad Oncology” or the “Company”) today announces, in accordance with Article 14 of the...

Information on the Total Number of Voting Rights and Shares (Article 15 of the Law of 2 May 2007)

MONT-SAINT-GUIBERT, Belgium, Dec. 15, 2023 (GLOBE NEWSWIRE) -- Celyad Oncology (Euronext: CYAD) (the “Company” or “Celyad Oncology”), today announces that 6,500,000 shares of CFIP CLYD (UK...

Celyad announces management change

MONT-SAINT-GUIBERT, Belgium, Dec. 04, 2023 (GLOBE NEWSWIRE) -- Celyad Oncology (Euronext: CYAD), a cutting-edge biotechnology company dedicated to pioneering the discovery and advancement of...

Publication of a transparency notification received from Tolefi SA (Article 14 §1 of the Law of 2 May 2007)

MONT-SAINT-GUIBERT, Belgium, Dec. 01, 2023 (GLOBE NEWSWIRE) -- regulated information – Celyad Oncology SA (Euronext: CYAD) (“Celyad Oncology” or the “Company”) today announced, in accordance...

Publication of a transparency notification received from Fortress Investment Group LLC (Article 14 §1 of the Law of 2 May 2007)

MONT-SAINT-GUIBERT, Belgium, Nov. 21, 2023 (GLOBE NEWSWIRE) -- Celyad Oncology SA (Euronext: CYAD) (“Celyad Oncology” or the “Company”) today announced, in accordance with Article 14 of the...

Information on the Total Number of Voting Rights and Shares (Article 15 of the Law of 2 May 2007)

MONT-SAINT-GUIBERT, Belgium, Nov. 14, 2023 (GLOBE NEWSWIRE) -- Celyad Oncology (Euronext: CYAD) (the “Company” or “Celyad Oncology”), today announces the below information following the...

Celyad Oncology reports third quarter 2023 financial results and recent business highlights

Publication of data detailing the development of our microRNA (miRNA)-based multiplex shRNA approach, which allows to down-regulate several genes simultaneously, in Molecular Therapy – Nucleic...

Celyad Oncology announces the termination of its American Depository Receipt program

MONT-SAINT-GUIBERT, Belgium, Sept. 25, 2023 (GLOBE NEWSWIRE) -- Celyad Oncology SA (Euronext: CYAD) (“Celyad Oncology” or the “Company”) today announces that Citibank, N.A., as depositary...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10.00050.20.250.280.25166860.26516206DE
4-0.0395-13.62068965520.290.3090.231181140.27038373DE
12-0.0605-19.45337620580.3110.32850.231151350.29144247DE
26-0.1095-30.41666666670.360.470.231201150.35619389DE
52-0.2895-53.61111111110.541.280.231333570.55406738DE
156-3.6995-93.65822784813.954.60.231371281.70927219DE
260-12.5295-98.039906103312.7813.480.231429684.78676566DE

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
WRNTWarrantee Inc
$ 0.8962
(207.97%)
11.84M
NMHINatures Miracle Holding Inc
$ 0.7982
(128.06%)
8.33M
FEIMFrequency Electronics Inc
$ 13.37
(32.38%)
122.96k
TUSKMammoth Energy Services Inc
$ 4.51
(28.86%)
74.15k
LGHLWLion Group Holding Ltd
$ 0.0091
(28.17%)
4.5k
RNAZTransCode Therapeutics Inc
$ 0.3236
(-59.17%)
434.09k
MIRAMIRA Pharmaceuticals Inc
$ 3.49
(-30.34%)
1M
BREABrera Holdings PLC
$ 0.5495
(-25.45%)
1.77M
CMAXCareMax Inc
$ 3.89
(-25.05%)
336.59k
NUKKNukkleus Inc
$ 0.4089
(-17.89%)
161.42k
WRNTWarrantee Inc
$ 0.8865
(204.64%)
11.88M
NMHINatures Miracle Holding Inc
$ 0.7997
(128.49%)
8.33M
LIFWMSP Recovery Inc
$ 0.5111
(0.87%)
4.7M
BREABrera Holdings PLC
$ 0.5495
(-25.45%)
1.77M
TSLLDirexion Daily TSLA Bull 2X Trust ETF
$ 14.48
(1.33%)
1.51M

Discussion

View Full Feed
TRUSTUNITS1000000 TRUSTUNITS1000000 4 minutes ago
Interesting drink design
FHBC
Omar8 Omar8 4 minutes ago
ANt4,



"Work-For-Hire Doctrine & Corporate Officers. Under the work-for-hire doctrine, an employee also serving as a corporate officer typically has a fiduciary duty to assign the patent rights for inventions created during his/her tenure to the company. To do otherwise
NNLX
TRUSTUNITS1000000 TRUSTUNITS1000000 4 minutes ago
Millions in sales a while back
FHBC
Monksdream Monksdream 5 minutes ago
WRNT will it grow more legs after 7:00
WRNT
HD2001 HD2001 5 minutes ago
If Nash took a lie detector test he'd break the machine the graft can't go that wide . Delay and deceive
XALL
TRUSTUNITS1000000 TRUSTUNITS1000000 5 minutes ago
Pull certs , what does that mean
AABB
learningcurve2020 learningcurve2020 6 minutes ago
BP doesn't need all this risky illegal land mines, they could buy broke tiny NWBO or Advent with the change in their pocket.
NWBO
MightyX MightyX 6 minutes ago
This move significantly diminishes inherent post-r/s risk
TPTW
TRUSTUNITS1000000 TRUSTUNITS1000000 7 minutes ago
Interesting marketing
VGID
TRUSTUNITS1000000 TRUSTUNITS1000000 8 minutes ago
Maybe they stopped selling drinks at trade shows
VGID
MightyX MightyX 8 minutes ago
Reflects huge long-term-investor gain overnight to offset retail bs.
TPTW
TRUSTUNITS1000000 TRUSTUNITS1000000 8 minutes ago
Wonder how it tasted
VGID
TRUSTUNITS1000000 TRUSTUNITS1000000 9 minutes ago
Neat drink design
VGID
TRUSTUNITS1000000 TRUSTUNITS1000000 9 minutes ago
No volume
FMNJ
TRUSTUNITS1000000 TRUSTUNITS1000000 10 minutes ago
Can buy u,s.
DCMDF
TRUSTUNITS1000000 TRUSTUNITS1000000 10 minutes ago
Interesting what they do
DCMDF
StockWorkOrange StockWorkOrange 12 minutes ago
Imagine that, Benny pops up and so does Alidare. This guy is as slimy as they come. Blocks and runs on ST and X when you expose him.....
AABB
TRUSTUNITS1000000 TRUSTUNITS1000000 12 minutes ago
Interesting 🤔 comment
AABB
Mark Mark 13 minutes ago
$WRNT & $NMHI top two gainers so far, one over 200%, one over 100%
NMHI WRNT
VDB1 VDB1 13 minutes ago
Lightwave Logic's choice to bring Le Maitre on board underscores the company's commitment to leadership with deep industry knowledge.

In other recent news, Lightwave Logic has made significant strides in its commercial strategy and technological advancements. The company has emphas
LWLG
Nerd Beautiful Nerd Beautiful 13 minutes ago
Two happy things I just remembered. Tony said there were good things in the works earlier this year. I just rediscovered the ignore this member button
LQMT
goldslacker2023 goldslacker2023 14 minutes ago
Words of wisdom; Be careful to not lock the knees. Better balance in the event there's ever a pendulum swing in life. Is it just me or have you noticed any volume lately in the OTC? Tread heavy. New tires but it cost me. You play you pay. Tallyho!
GNCP
TRUSTUNITS1000000 TRUSTUNITS1000000 14 minutes ago
TGGI huge company in the making, maybe
TGGI
WooptdooU WooptdooU 14 minutes ago
Maybe this guy will help get the ceo and cob into separate bodies. Right now you have a KNOWN MISGUIDER acting as both! This , ahem, "expert witness" corporate welfarist has groomed his family long enough off the back of capitalism...
LWLG
Awl416 Awl416 14 minutes ago
New lows
DRMA

Your Recent History

Delayed Upgrade Clock